In AD, elevated levels of HSD10 were found in affected brain regions, where HSD10 is considered to mediate amyloid-β peptide (Aβ)-associated cytotoxicity, and this interplay is thought to be one of the possible aspects of AD pathogenesis [9, 10]. The gene discussed is FSIP1; the disease is Alzheimer disease.